2,194 Shares in DaVita Inc. (NYSE:DVA) Acquired by E Fund Management Co. Ltd.

E Fund Management Co. Ltd. bought a new stake in shares of DaVita Inc. (NYSE:DVA) during the fourth quarter, HoldingsChannel reports. The fund bought 2,194 shares of the company’s stock, valued at approximately $328,000.

Several other hedge funds also recently bought and sold shares of the stock. FMR LLC lifted its position in shares of DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after acquiring an additional 154,061 shares in the last quarter. Glenmede Trust Co. NA raised its stake in DaVita by 731.6% in the 3rd quarter. Glenmede Trust Co. NA now owns 123,269 shares of the company’s stock valued at $20,207,000 after purchasing an additional 108,446 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after purchasing an additional 92,014 shares in the last quarter. KBC Group NV boosted its stake in shares of DaVita by 27.3% during the 3rd quarter. KBC Group NV now owns 313,519 shares of the company’s stock worth $51,395,000 after purchasing an additional 67,250 shares during the last quarter. Finally, Strategic Financial Concepts LLC purchased a new stake in shares of DaVita during the fourth quarter worth about $9,371,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DVA. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Finally, Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Price Performance

DaVita stock opened at $146.73 on Friday. DaVita Inc. has a 1 year low of $125.64 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The firm has a 50 day moving average price of $159.43 and a 200 day moving average price of $157.90. The company has a market cap of $11.74 billion, a price-to-earnings ratio of 13.66, a PEG ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.